ImmunoPrecise Antibodies Ltd.
NASDAQ:IPA
Overview | Financials
Company Name | ImmunoPrecise Antibodies Ltd. |
Symbol | IPA |
Currency | USD |
Price | 0.418 |
Market Cap | 11,249,329 |
Dividend Yield | 0% |
52-week-range | 0.402 - 2.6 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Jennifer Lynne Bath Ph.D. |
Website | https://www.ipatherapeutics.com |
An error occurred while fetching data.
About ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD